Rational for drug dosimetry and duration of terbinafine in the context of recalcitrant dermatophytosis: Is 500 mg better than 250 mg OD or BD?
Main Authors: | Kabir Sardana, Aastha Gupta |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Indian Journal of Dermatology |
Online Access: | http://www.e-ijd.org/article.asp?issn=0019-5154;year=2017;volume=62;issue=6;spage=557;epage=559;aulast=Sardana |
Similar Items
-
Efficacy and safety of terbinafine 500 mg once daily in patients with dermatophytosis
by: P Ravindra Babu, et al.
Published: (2017-01-01) -
Super bioavailable itraconazole and its place and relevance in recalcitrant dermatophytosis: Revisiting skin levels of itraconazole and minimum inhibitory concentration data
by: Kabir Sardana, et al.
Published: (2021-01-01) -
Relapse after oral terbinafine therapy in dermatophytosis: A clinical and mycological study
by: Imran Majid, et al.
Published: (2016-01-01) -
Fulvestrant (Fazlodeks)v dozirovke 500 mg uvelichivaet medianuobshchey vyzhivaemosti na 4,1 mes po sravneniyus dozirovkoy 250 mg
by: - -
Published: (2012-12-01) -
Looking Beyond the Cyclosporine “Swish and Spit” Technique in a Recalcitrant Case of Erosive Lichen Planus Involving the Tongue
by: Aastha Gupta, et al.
Published: (2017-10-01)